Vestmark Advisory Solutions Inc. Sells 203 Shares of CorVel Co. (NASDAQ:CRVL)

Vestmark Advisory Solutions Inc. trimmed its holdings in CorVel Co. (NASDAQ:CRVL) by 1.9% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 10,391 shares of the business services provider’s stock after selling 203 shares during the period. Vestmark Advisory Solutions Inc.’s holdings in CorVel were worth $2,569,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also bought and sold shares of CRVL. Rhumbline Advisers boosted its position in CorVel by 0.4% in the third quarter. Rhumbline Advisers now owns 28,585 shares of the business services provider’s stock worth $5,621,000 after purchasing an additional 103 shares during the last quarter. SkyView Investment Advisors LLC increased its holdings in CorVel by 3.3% during the third quarter. SkyView Investment Advisors LLC now owns 3,789 shares of the business services provider’s stock valued at $745,000 after buying an additional 121 shares during the last quarter. Deutsche Bank AG increased its holdings in CorVel by 3.1% during the third quarter. Deutsche Bank AG now owns 4,544 shares of the business services provider’s stock valued at $894,000 after buying an additional 136 shares during the last quarter. Wesbanco Bank Inc. boosted its stake in shares of CorVel by 7.0% during the 3rd quarter. Wesbanco Bank Inc. now owns 3,040 shares of the business services provider’s stock worth $598,000 after acquiring an additional 200 shares during the last quarter. Finally, Yousif Capital Management LLC grew its position in shares of CorVel by 4.3% during the 4th quarter. Yousif Capital Management LLC now owns 5,060 shares of the business services provider’s stock valued at $1,251,000 after acquiring an additional 207 shares during the period. Institutional investors own 51.36% of the company’s stock.

CorVel Price Performance

Shares of CRVL stock traded up $0.94 during trading hours on Friday, reaching $242.51. 22,564 shares of the company traded hands, compared to its average volume of 28,803. The firm has a 50-day moving average price of $243.19 and a 200 day moving average price of $231.83. The company has a market cap of $4.15 billion, a P/E ratio of 56.14 and a beta of 1.08. CorVel Co. has a 12-month low of $187.92 and a 12-month high of $265.14.

Insider Buying and Selling at CorVel

In other news, Director Steven J. Hamerslag sold 2,000 shares of the stock in a transaction on Thursday, February 8th. The shares were sold at an average price of $239.95, for a total value of $479,900.00. Following the completion of the sale, the director now directly owns 114,389 shares of the company’s stock, valued at $27,447,640.55. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, Director Steven J. Hamerslag sold 2,000 shares of the company’s stock in a transaction dated Thursday, February 8th. The stock was sold at an average price of $239.95, for a total value of $479,900.00. Following the completion of the transaction, the director now owns 114,389 shares of the company’s stock, valued at $27,447,640.55. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Michael G. Combs sold 301 shares of CorVel stock in a transaction that occurred on Tuesday, February 13th. The shares were sold at an average price of $246.82, for a total value of $74,292.82. Following the sale, the chief executive officer now directly owns 21,082 shares in the company, valued at approximately $5,203,459.24. The disclosure for this sale can be found here. Insiders have sold 11,543 shares of company stock valued at $2,881,792 over the last 90 days. 48.71% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Separately, StockNews.com cut CorVel from a “buy” rating to a “hold” rating in a report on Friday.

About CorVel

CorVel Corporation provides workers' compensation, auto, liability, and health solutions for employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs.